Phenotypic and Genotypic Characterization and Treatment of a Cohort With Familial Tumoral Calcinosis/Hyperostosis‐Hyperphosphatemia Syndrome

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Journal of Bone and Mineral Research

• Publication date

  2016-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/jbmr.2870PMID 27164190PMCID PMC5071128
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Acetazolamide sensitive tissue calcification and aging of klotho-hypomorphic mice

  2015cited by this paper
• Human Preosteoblastic Cell Culture from a Patient with Severe Tumoral Calcinosis-Hyperphosphatemia Due to a New GALNT3 Gene Mutation: Study of In Vitro Mineralization

  2015cited by this paper
• Rare Bone Diseases and Their Dental, Oral, and Craniofacial Manifestations

  2014cited by this paper
• Severe vascular calcification and tumoral calcinosis in a family with hyperphosphatemia: a fibroblast growth factor 23 mutation identified by exome sequencing.

  2014cited by this paper
• Hyperphosphatemic familial tumoral calcinosis: Response to acetazolamide and postulated mechanisms

  2014cited by this paper
• Fibrodysplasia ossificans progressiva: diagnosis, management, and therapeutic horizons.

  2013cited by this paper
• Fibroblast growth factor 23: state of the field and future directions.

  2012cited by this paper
• Tumoral Calcinosis—A Pathogenetic Overview

  2012cited by this paper
• Mechanism of FGF23 processing in fibrous dysplasia

  2012cited by this paper
• Tumoral calcinosis: a dental literature review and case report.

  2012cited by this paper
• Novel mutations in GALNT3 causing hyperphosphatemic familial tumoral calcinosis

  2011cited by this paper
• Revised reference curves for bone mineral content and areal bone mineral density according to age and sex for black and non-black children: results of the bone mineral density in childhood study.

  2011cited by this paper
• Tumor-induced osteomalacia.

  2011cited by this paper
• Clinical variability of familial tumoral calcinosis caused by novel GALNT3 mutations

  2010cited by this paper
• Familial Tumoral Calcinosis Caused by a Novel FGF23 Mutation: Response to Induction of Tubular Renal Acidosis with Acetazolamide and the Non-Calcium Phosphate Binder Sevelamer

  2009cited by this paper
• Isolated C-terminal tail of FGF23 alleviates hypophosphatemia by inhibiting FGF23-FGFR-Klotho complex formation

  2009cited by this paper
• Medical Treatment for Tumoral Calcinosis with Eight Years of Follow-up: A Report of Four Cases

  2009cited by this paper
• A case of familial tumoral calcinosis/hyperostosis–hyperphosphatemia syndrome due to a compound heterozygous mutation in GALNT3 demonstrating new phenotypic features

  2009cited by this paper
• A homozygous missense mutation in human KLOTHO causes severe tumoral calcinosis.

  2007cited by this paper
• Polypeptide GalNAc-transferase T3 and Familial Tumoral Calcinosis

  2006cited by this paper
• The role of mutant UDP-N-acetyl-alpha-D-galactosamine-polypeptide N-acetylgalactosaminyltransferase 3 in regulating serum intact fibroblast growth factor 23 and matrix extracellular phosphoglycoprotein in heritable tumoral calcinosis.

  2006cited by this paper
• Efficacy of probenecid for a patient with juvenile dermatomyositis complicated with calcinosis.

  2006cited by this paper
• A novel homozygous missense mutation in FGF23 causes Familial Tumoral Calcinosis associated with disseminated visceral calcification

  2005cited by this paper
• Tumor-induced osteomalacia.

  2005cited by this paper
• An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia.

  2005cited by this paper
• Mutations in GALNT3, encoding a protein involved in O-linked glycosylation, cause familial tumoral calcinosis

  2004cited by this paper
• Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia.

  2003cited by this paper
• Sevelamer hydrochloride: an effective phosphate binder in dialyzed children

  2003cited by this paper
• Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia.

  2003cited by this paper
• Autosomal-dominant hypophosphatemic rickets (ADHR) mutations stabilize FGF-23.

  2001cited by this paper
• Hyperostosis with hyperphosphatemia: evidence of familial occurrence and association with tumoral calcinosis.

  1997cited by this paper
• Successful treatment of hyperphosphatemic tumoral calcinosis with long-term acetazolamide.

  1995cited by this paper
• Assessment and interpretation of the tubular threshold for phosphate in infants and children

  1994cited by this paper
• Assessment and interpretation of the tubular threshold for phosphate in infants and children

  1994cited by this paper
• Head and neck manifestations of tumoral calcinosis.

  1994cited by this paper
• Familial Tumoral Calcinosis: A Clinical, Histopathologic, and Ultrastructural Study with an Analysis of its Calcifying Process and Pathogenesis

  1993cited by this paper
• Dental lesions in tumoral calcinosis.

  1991cited by this paper
• Quantification of coronary artery calcium using ultrafast computed tomography.

  1990cited by this paper
• Phosphorus excretion in tumoral calcinosis: response to parathyroid hormone and acetazolamide.

  1980cited by this paper
• TUMORAL CALCINOSIS: A METABOLIC DISEASE OF OBSCURE ETIOLOGY.

  1965cited by this paper

• A Large Deletion With a Large Impact: Homozygous 5,600 bp Deletion of the GALNT3 Gene Causing Hyperphosphatemic Tumoral Calcinosis

  2026cites this paper
• Calcinosis Circumscripta with Iron Mineralization in an African Green Monkey (Chlorocebus aethiops sabaeus)

  2025cites this paper
• Tumoral calcinosis: a rare and disabling bone disorder

  2025cites this paper
• Inflammation-Induced Klotho Deficiency: A Possible Key Driver of Chronic Kidney Disease Progression

  2025cites this paper
• Calcinosis cutis of the lower legs – hyperphosphatemic familial tumoral calcinosis in a patient with GALNT3 mutation

  2025cites this paper
• The Complexities and Challenges of Managing Genetic Causes of Hyperphosphataemia, a Case Report

  2025cites this paper
• Uremic Pericarditis in a Patient With Hyperphosphatemic Familial Tumoral Calcinosis: Case Report

  2025cites this paper
• Phosphate in Physiological and Pathological Mineralization: Important yet Often Unheeded

  2025cites this paper
• Calcinosis cutis der Unterschenkel – Hyperphosphatämische familiäre tumorale Kalzinose bei einem Patienten mit GALNT3‐Mutation

  2025cites this paper
• Causal effects and mediation pathways of circulating plasma proteins on osteoporosis: a two-sample and two-step Mendelian randomization study

  2025cites this paper
• Hyperphosphatemic Familial Tumoral Calcinosis With a Large Hip Mass

  2025cites this paper
• A Sole Case of the FGF23 Gene Mutation c.202A>G (p.Thr68Ala) Associated with Multiple Severe Vascular Aneurysms and a Hyperphosphatemic Variant of Tumoral Calcinosis—A Case Report

  2024cites this paper
• Successful treatment approaches for tumoral calcinosis in children and young people: A condition of diverse pathogenesis.

  2024cites this paper
• Two cases of hyperphosphatemic familial tumoral calcinosis with varied etiology and unique presentations

  2024cites this paper
• Familial tumoral calcinosis: a rare autosomal recessive disease

  2024cites this paper
• Inherited phosphate and pyrophosphate disorders: New insights and novel therapies changing the oral health landscape.

  2024cites this paper
• A GALNT3 mutation causing Hyperphosphatemic familial Tumoral calcinosis

  2024cites this paper
• Structural and Molecular Imaging-based Characterization of Soft Tissue and Vascular Calcification in Hyperphosphatemic Familial Tumoral Calcinosis.

  2024cites this paper
• Spatial Atlas for Mapping Vascular Microcalcification Using 18F-NaF PET/CT: Application in Hyperphosphatemic Familial Tumoral Calcinosis

  2024cites this paper
• Rare and Common Variants in GALNT3 May Affect Bone Mass Independently of Phosphate Metabolism

  2023influential citation
• Clinical Characteristics, Therapeutic Options, and Outcomes in Hyperphosphatemic Tumoral Calcinosis: A Systematic Review

  2023cites this paper
• Hyperphosphatemic familial tumoral calcinosis with hyperphosphatemic hyperostosis due to a novel mutation: Severe presentation of a rare disorder

  2023cites this paper
• Effectiveness of topical sodium thiosulfate for ectopic calcifications and ossifications. Results of the CATSS-O study.

  2023cites this paper
• Venous Thrombosis in a Pseudohypoparathyroidism Patient with a Novel GNAS Frameshift Mutation and Complete Resolution of Vascular Calcifications with Acetazolamide Treatment

  2023cites this paper
• Hyperphosphatemia With Normal Kidney Function Associated With Genetic Variants of GALNT3

  2023cites this paper
• Elderly-onset calcinosis of hyperphosphataemic familial tumoural calcinosis/hyperostosis-hyperphosphataemia syndrome: the role of comorbid scleroderma

  2023cites this paper
• Multiple brown tumors: a bone complication due to long-term untreated pseudohypoparathyroidism

  2023cites this paper
• A rare case of Hyperphosphatemic Tumoral Calcinosis in a 13 year old Nigerian boy

  2023cites this paper
• Canakinumab in addition to phosphate-binding and phosphaturia-inducing therapy were effective in achieving remission in a child with a large familial calcinotic tumour

  2023cites this paper
• Genome-wide analyses of gene expression profile identify key genes and pathways involved in skeletal response to phosphate and 1,25-dihydroxyvitamin D3 in vivo.

  2023cites this paper
• A case of hyperphosphatemic familial tumoral calcinosis due to maternal uniparental disomy of a GALNT3 variant

  2023cites this paper
• Minéralisation ectopique chez l'enfant

  2023cites this paper
• Therapeutic Management of Symptomatic Calcification in a Patient With Normophosphatemic Tumoral Calcinosis

  2023cites this paper
• Determination of FGF23 Levels for the Diagnosis of FGF23‐Mediated Hypophosphatemia

  2022cites this paper
• Phosphate Homeostasis and Disorders of Phosphate metabolism.

  2022cites this paper
• A Rare Case of Bilateral Hip Tumoral Calcinosis With Intertrochanteric Fracture Treated by Closed Reduction Internal Fixation (CRIF) Using a Proximal Femoral Nail

  2022cites this paper
• A novel FGF23 mutation in hyperphosphatemic familial tumoral calcinosis and its deleterious effect on protein O-glycosylation

  2022influential citation
• Skeletal and extraskeletal disorders of biomineralization

  2022cites this paper
• Disorders of phosphate homeostasis in children, part 2: hypophosphatemic and hyperphosphatemic disorders

  2022cites this paper
• Relationship between rs7586085, GALNT3 and CCDC170 gene polymorphisms and the risk of osteoporosis among the Chinese Han population

  2022cites this paper
• Hyperphosphatemic Tumoral Calcinosis With Pemigatinib Use

  2022cites this paper
• Sedimentation sign: a classical finding on tumorous calcinosis

  2022cites this paper
• Polypeptide N-acetylgalactosaminyltransferase-Associated Phenotypes in Mammals

  2021cites this paper
• The Successful Treatment of Deep Soft-tissue Calcifications with Topical Sodium Thiosulphate and Acetazolamide in a Boy with Hyperphosphatemic Familial Tumoral Calcinosis due to a Novel Mutation in FGF23

  2021influential citation
• Treatment of pseudoxanthoma elasticum with probenecid

  2021cites this paper
• A Cross‐Sectional Cohort Study of the Effects of FGF23 Deficiency and Hyperphosphatemia on Dental Structures in Hyperphosphatemic Familial Tumoral Calcinosis

  2021cites this paper
• FGF23 as a drug target

  2021cites this paper
• The discovery of FGF23—a historic view

  2021cites this paper
• Primary hyperphosphatemic tumoral calcinosis: a case report

  2021cites this paper
• Bone Involvement in Hyperphosphatemic Familial Tumoral Calcinosis: A New Phenotypic Presentation

  2021cites this paper
• Hyperphosphatemic Familial Tumoral Calcinosis Hidden in Plain Sight for 73 Years: A Case Report

  2021cites this paper
• Hyperphosphatemia increases inflammation to exacerbate anemia and skeletal muscle wasting independently of FGF23-FGFR4 signaling

  2021cites this paper
• PTH and FGF23 Exert Interdependent Effects on Renal Phosphate Handling: Evidence From Patients With Hypoparathyroidism and Hyperphosphatemic Familial Tumoral Calcinosis Treated With Synthetic Human PTH 1–34

  2021cites this paper
• Hyperphosphatämische familiäre tumorale Kalzinose bei zwei Geschwistern

  2021cites this paper
• Hyperphosphatemic Tumoral Calcinosis: Pathogenesis, Clinical Presentation, and Challenges in Management

  2020influential citation
• Hyperphosphataemic familial tumoral calcinosis: case report of a rare and challenging disease

  2020cites this paper
• Defective O-glycosylation of novel FGF23 mutations in a Chinese family with hyperphosphatemic familial tumoral calcinosis.

  2020cites this paper
• IL‐1β Drives Production of FGF‐23 at the Onset of Chronic Kidney Disease in Mice

  2020influential citation
• Hyperphosphatemic familial tumoral calcinosis caused by a novel variant in the GALNT3 gene

  2020cites this paper
• Congenital Hyperphosphatemic Conditions Caused by the Deficient Activity of FGF23

  2020cites this paper
• Phosphorus homeostasis and related disorders

  2020cites this paper
• Bone- and cartilage-forming tumors and tumors of joints

  2020cites this paper
• Selective pharmacological inhibition of the sodium-dependent phosphate co-transporter NPT2a promotes phosphate excretion.

  2020cites this paper
• The EPO-FGF23 Signaling Pathway in Erythroid Progenitor Cells: Opening a New Area of Research

  2019cites this paper
• CDG and immune response: From bedside to bench and back

  2019cites this paper
• Extraskeletal Calcifications in Hutchinson-Gilford Progeria Syndrome.

  2019cites this paper
• Complete heart block in a boy with hyperostosis–hyperphosphataemia syndrome: a case report

  2019influential citation
• Clinical and genetic analysis of idiopathic normophosphatemic tumoral calcinosis in 19 patients

  2019cites this paper
• Hyperphosphatemic Familial Tumoral Calcinosis With Galnt3 Mutation: Transient Response to Anti‐Interleukin‐1 Treatments

  2019cites this paper
• αKlotho–FGF23 interactions and their role in kidney disease: a molecular insight

  2019cites this paper
• Primary tumor (tumoral) calcification is a rare disease in the practice of a rheumatologist and orthopedist: experience with the use of an interleukin-1 inhibitor in combination with surgical correction

  2019cites this paper
• Hyperphosphatemic tumoral calcinosis caused by FGF23 compound heterozygous mutations: what are the therapeutic options for a better control of phosphatemia?

  2018cites this paper
• Tumoral Calcinosis – Dermatomyositis

  2018cites this paper
• Disorders of Phosphate Homeostasis

  2018cites this paper
• Hyperphosphatemic Familial Tumoral Calcinosis in Two Siblings with a Novel Mutation in GALNT3 Gene: Experience from Southern Turkey

  2018cites this paper
• Disorders and Mechanisms of Ectopic Calcification

  2018cites this paper
• A Novel Mutation in FGF23 Causing Severe Manifestation of Hyperphosphataemic Familial Tumoral Calcinosis

  2018influential citation
• Phosphate as a Signaling Molecule and Its Sensing Mechanism.

  2018cites this paper
• Hyperphosphatemic familial tumoral calcinosis secondary to fibroblast growth factor 23 (FGF23) mutation: a report of two affected families and review of the literature

  2018cites this paper
• Bone involvement in monogenic autoinflammatory syndromes

  2018cites this paper
• Delineating the mechanisms underlying rare disorders of ectopic calcification to reveal novel therapeutic strategies

  2017cites this paper
• Disorders related to calcium metabolism

  2017cites this paper
• A Case of Hyperphosphatemia and Elevated Fibroblast Growth Factor 23: A Brief Review of Hyperphosphatemia and Fibroblast Growth Factor 23 Pathway

  2017cites this paper
• Genetic diseases resulting from disordered FGF23/klotho biology.

  2017cites this paper
• Efficacy of intralesional sodium thiosulfate injections for disabling tumoral calcinosis: Two cases.

  2017cites this paper
• Evaluation of a New Fully Automated Assay for Plasma Intact FGF23

  2017cites this paper
• Clinical Utility Gene Card For: GALNT3 defective congenital disorder of glycosylation

  2017cites this paper
• Identification of two novel mutations in the GALNT3 gene in a Chinese family with hyperphosphatemic familial tumoral calcinosis

  2016cites this paper
• Régulation endocrine de la phosphatémie : de l’identification des facteurs aux nouvelles thérapies

  2016cites this paper
• [Endocrine control of serum phosphate: from the discoveries of phosphatonins to novel therapies].

  2016cites this paper
• Clinical utility gene card for: ALG6 defective congenital disorder of glycosylation

  2014cites this paper